Bio/Pharma Business

Illuminating the State of Outsourcing with Stephen Holdsworth (DCAT 2023)

March 27, 2023

Stephen Holdsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.

Ingredion Announces Strategic Investments in India Expanding into High-Value Pharmaceutical Ingredients

March 27, 2023

Ingredion has completed two strategic investments in India with Amishi Drugs & Chemicals and Mannitab Pharma Specialties.

Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement

March 24, 2023

Harm Reduction Therapeutics and Catalent have signed a commercial supply agreement for naloxone nasal spray to reverse opioid overdoses.

Invitae and Deerfield Management Team Up on Novel Therapeutics for Rare Diseases

March 22, 2023

Under a new partnership, Invitae and Deerfield Management will harness genetic and clinical testing data from patients to discover potential novel therapeutics for treating rare diseases.

Sanofi Drops Lantus US List Price by 78%, Capping Out-of-Pocket Costs at $35

March 21, 2023

Sanofi intends to cut its US list price for Lantus (insulin glargine injection) by 78% and cap out-of-pocket costs at $35 for all patients with commercial insurance.

BioNTech and OncoC4 to Co-Develop mAb for Solid Tumor Indications

March 21, 2023

BioNTech will receive an exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 mAb candidate for solid tumor indications.

Sartorius and Teknova Team Up for Gene Therapy Process Development

March 21, 2023

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics to Build Plant 5 as Part of Capacity Expansion to Bio Campus II

March 21, 2023

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

DCAT 2023 Highlights

March 20, 2023

Highlights from DCAT Week 2023, hosted from March 20 - March 25.

Genuv and Celltrion Partner on Development of Novel Therapeutic Antibodies

March 17, 2023

The collaboration between Genuv and Celltrion will utilize Genuv's proprietary mouse platform for antibody discovery.